Skip to main content

Scientific Programme

The scientific programme of the ESMINT Congress 2026 will offer a wide range of topics, teaching formats and training opportunities in the field of neurointerventions. There will be three full-days with state-of-the-art presentations, live moderation and discussions.

Wednesday, 2 Sep 2026

Thursday, 3 Sep 2026

Friday, 4 Sep 2026

Wednesday, 2 Sep 2026

Main ESMINT Programme

Room: Main Lecture Hall

Time Session
08:00–08:10 Welcome and Introduction
08:10–09:00 The best & worst studies

The best studies of the last decade and what you didn´t know about them
The worst studies of the last decade and what you didn´t know about them
09:00-09:30 Scientific Abstract Session I
09:30-09:45 Honorary Membership
09:45-10:00 Industry Symposium
10:00–10:30 Coffee Break & Meet the Oracle
10:30–12:00 Joint Session with EANS

1. Chronic vessel occlusions
Chronic vessel occlusions should primarily be treated with bypass surgery.
Chronic vessel occlusions: Why Endovascular Recanalization Should Be First-Line
2. Fusiform posterior circulation aneurysms
Natural history and time point of treatment
Posterior circulation aneurysms: No Bypass, No Solution
Fusiform posterior circulation aneurysms: endovascular only
3. Emergency bypass in acute stroke
12:00-12:30 Scientific Abstracts Session II
12:30–13:00 Industry Symposium
13:00–14:00 Lunch Break
14:00–14:30 Industry Symposium
14:30–16:00 Joint Meeting with SNIS I

1. Amy Walters Patient Lecture

Carotid stenting then and now
2. CREST-2: Reasons behind CAS success
3. Selection criteria including plaque imaging, classification
4. Impact of Embolic Protection in CAS
5. new devices (CARESTO study)
6. Carotid WEB
7. Tandem and dissections
8. Panel discussion
15:45–16:00 Start-ups Session
16:00–16:30 Coffee Break & Meet the Oracle
16:30–16:45 Industry Symposium
16:45–18:00 Joint Session with SNIS II

Contemporary Management of Brain AVMs and dAVF
1. State of the art: Recent Advances in the Management of Brain AVMs
2. Brain AVM: how to use EVT, surgery and Radiosurgery for best patient outcomes
3. Innovation: New device
4. Special population: Management of Paediatric Head, Neck, Face, and Orbital Vascular Malformation
5. Reflection and debate: SNIS and ESMINT case discussion
18:00–19:00 ESMINT General Assembly

Thursday, 3 Sep 2026

Main ESMINT Programme

Room: Main Lecture Hall

Time Session
08:00–08:10 Highlights from Day 1
08:10–08:40 Scientific Abstract Session III
08:40-09:25 Precision meets pressure – inside the life of an INR

1. Invisible risk: radiation in INR and protection strategies
2. The unseen wound of INR – the weight of complications
3. Patient-ready or procedure-centered – the organization of an INR department
4. Call-schedule versus life-schedule – the new INR paradigm
09:25-09:45 Awards Session
09:45-10:00 Industry Symposium
10:00–10:30 Coffee Break & Meet the Oracle
10:30–12:30 Joint Session with ESO: Stroke Treatment – A blast from the past

1. IV Thrombolysis — History, Pharmacology, and Clinical Essentials
2. Intra-Arterial Therapy Through the Neurologist’s Lens: Indications, Evidence, and Expectations
3. Intra-Arterial Adjuncts from the Angio Suite: A Neurointerventional Perspective
4. Neuroprotection in the Thrombectomy Era: Old Concepts, New Possibilities
5. From Evidence to Action: Integrating Thrombolysis and Neuroprotection into Daily Practice
12:30–13:00 Industry Symposium
13:00–14:00 Lunch Break
14:00–14:30 Industry Symposium
14:30–14:45 Research Grants
14:45–15:05 Inspirational Talk
15:05–16:00 Exploring new paths: Endovascular Frontiers in Neurooncology

1. Intra-Arterial Chemotherapy for Retinoblastoma: The Current State of the Art
2. Meningioma Embolization Revisited: Pre-Operative Tool or Stand-Alone Therapy?
3. Can we already Treat Malignant Brain Tumors Endovascularly?
4. How to access the brain in the future?
16:00–16:30 Coffee Break & Meet the Oracle
16:30–17:30 New Technology Symposium
17:30–17:40 ESMINT Diploma Ceremony
17:40–18:25 Ongoing & Final Trials Session

Friday, 4 Sep 2026

Main ESMINT Programme

Room: Main Lecture Hall

Time Session
08:30–08:40 Highlights from Day 1
08:40–09:10 We are the ESMINT

1. How has education and training in INR changed over the decades and what we could expect in the future?
2. Reports from ESMINT educational programme alumni (ECMINT, EXMINT, Skills Training, Fellowship / Observership, e-Fellowship, NeuroXChange)
3. EastMINT: Remote Expertise, Real-Time Impact
09:10-09:30 Building Sustainable Stroke Systems: Europe and Beyond

1. Sustaining 24/7 Stroke Care Across Europe
2. Malaysias Stroke System: Constraints and Creativity
09:30-10:00 Scientific Abstract Session IV
10:00–10:30 Coffee Break & Meet the Oracle
10:30-11:00 Industry Symposium
11:00–11:45 The MMA: My best buddy

1. What clinical trials demonstrate, and what their results do NOT show
2. Complications of Middle Meningeal Artery (MMA) Embolization
3. Embolization Materials: Advantages and Efficacy
4. “Single-Stop” and Future Strategies for Chronic Subdural Hematoma (cSDH) Combined MMA embolization and hematoma drainage in one procedure, including:
• The Embolization SEPS concept
• The Embodrain system
11:45–12:30 The Venous Side of the Brain

1. Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Current Evidence and Best Practice
2. Venous Causes of Pulsatile Tinnitus: from Diagnosis to Interventional Treatment (Dorothea Altschul)
3. Transvenous Shunting: When the Vein Is the Target
4. Maxillofacial vascular malformations: specific considerations regarding therapy
12:30–12:55 Scientific Abstract Session V
12:55–13:00 Passing the Torch: Meet the 2027 Congress President!
13:00–14:00 Lunch Break
14:00–14:30 Late Breaking Abstracts
14:30–15:30 I Can See Clearly Now – The Blur is Gone

1. Flat-Panel Angiography in Focus: Unmasking the Hidden BAPAs
2. Perimesencephalic SAH: Still Benign or Just Misunderstood?
3. Risk of overdiagnosis: do we need to treat everything we see
4. Secondary MeVOs: What Flat-Panel Perfusion Reveals Beyond DSA
5. Flat-Panel CTA in Flow Diversion
15:30–16:30 The case that changed me
16:30–16:40 Final Remarks/Closing